4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-24-071961
Options or other derivatives
- Director acquired 5,799 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Saad Mark E Director | 2024-06-07 | Grant or award · Stock Option (Right to Buy) | +5,799 | 5,799 | D | ||
Loading xslF345X05/ownership.xml…